Study On Effect Of Slidenafil in intrauterine growth restrictio
Phase 4
Completed
- Conditions
- Health Condition 1: O94- Sequelae of complication of pregnancy, childbirth, and the puerperiumHealth Condition 2: O94- Sequelae of complication of pregnancy, childbirth, and the puerperium
- Registration Number
- CTRI/2019/01/017354
- Lead Sponsor
- I
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 200
Inclusion Criteria
Effective fetal weight less than 10 percentile for gestational age at 28 TO 29 weeks of pregnancy
Fetal abdominal circumference less than 5 Percentile for gestational age at 28 TO 29 weeks of pregnancy
Exclusion Criteria
Any Kind of fetal malformation
Congenital defects in foetus
Use of any other vasodilator agent by pregnant mother during the course of study
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method